1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Immetacyte Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial) cyclophosphamide, fludarabine, IL-2 (Proleukin) - Ovarian Cancer Metastatic | Phase 1 / Phase 2 | Withdrawn | Immetacyte Ltd | 2020-07-01 | 2020-12-16 |
Cyclophosphamide (1) · Interleukin-2 (1) · aldesleukin (1) · fludarabine (1)
United Kingdom (1)
Fiona Thistlethwaite, PhD, MRCP (1)
2019 (1)